MDM2 and renal cell carcinoma: Under the dominant model, the combined GT + GG genotypes of MDM2 rs2279744 demonstrated a borderline association with RCC risk (OR = 1.63, 95% CI = 0.98–2.69, p = 0.0732, Table 3, middle panel).